Pharmacy Website
    Clinic Website

    Intelligence » Lymphoma » Last Week

    Subscribe to get latest posts via email or subscribe to a RSS feed.

    NICE rejects Novartis’ CAR-T Kymriah for adult lymphoma

    Wednesday, September 19, 2018 -- The National Institute for Health and Care Excellence has turned down NHS funding for use of Novartis’ CAR-T therapy Kymriah in adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

    Two Independent Variables Found to Be Prognostic in Diffuse Large B-Cell Lymphoma

    Tuesday, September 18, 2018 -- Baseline ctDNA levels and, separately, measures of molecular response, were prognostic for outcome in patients with diffuse large B-cell lymphoma.